Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV

Clinical trial NCT00863239 · COMPLETED

Trial details

NCT number: NCT00863239
Sponsor: Biolex Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2009-03-01
Primary completion: 2010-11-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.